Importance Reliable prevalence estimates are lacking for young-onset dementia (YOD), in
which symptoms of dementia start before the age of 65 years. Such estimates are needed for …

Importance The behavioral variant of Alzheimer disease (bvAD) is characterized by early
and predominant behavioral deficits caused by AD pathology. This AD phenotype is …

Introduction To generalize safety and efficacy findings, it is essential that diverse populations
are well represented in Alzheimer's disease (AD) drug trials. In this review, we aimed to …

Algorithms for computer-aided diagnosis of dementia based on structural MRI have
demonstrated high performance in the literature, but are difficult to compare as different data sets …

Objective To evaluate cerebrospinal fluid ( CSF ) and serum neurofilament light chain (NfL)
levels in genetic frontotemporal dementia ( FTD ) as a potential biomarker in the …

Introduction Lumbar puncture (LP) is increasingly performed in memory clinics. We investigated
patient‐acceptance of LP, incidence of and risk factors for post‐LP complications in …

Background Frontotemporal dementia is a heterogenous neurodegenerative disorder, with
about a third of cases being genetic. Most of this genetic component is accounted for by …

Objective To estimate the prevalence of amyloid positivity, defined by positron emission
tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, …

Background Neurofilament light chain (NfL) is a promising blood biomarker in genetic
frontotemporal dementia, with elevated concentrations in symptomatic carriers of mutations in GRN…

Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF)
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …